Subject(s)
Atropine/therapeutic use , Dextroamphetamine/therapeutic use , Dopamine Agents/therapeutic use , Exotropia/drug therapy , Myopia/drug therapy , Nystagmus, Congenital/drug therapy , Retinal Degeneration/drug therapy , Strabismus/diagnosis , Terrorism , Exotropia/complications , Humans , New York City , Nystagmus, Congenital/complications , Retinal Degeneration/complications , Virginia , Vision, BinocularABSTRACT
A case is reported of a 10-year-old girl with prepapillary vascular loops. These are normal blood vessels of excessive length, usually arterial, that project from the optic disc into the vitreous cavity. Stereoscopic photographs and fluorescein angiographs of the condition are presented.
Subject(s)
Eye Abnormalities/diagnosis , Retinal Artery/abnormalities , Child , Female , Fluorescein Angiography , Humans , Retinal Artery/pathology , Visual AcuitySubject(s)
Atropine/therapeutic use , Eyeglasses , Mydriatics/therapeutic use , Myopia/therapy , Child , Child, Preschool , Combined Modality Therapy , HumansSubject(s)
Adaptation, Ocular/physiology , Convergence, Ocular/physiology , Depth Perception/physiology , Duane Retraction Syndrome/surgery , Strabismus/surgery , Trochlear Nerve Diseases/surgery , Child , Child, Preschool , Diplopia/physiopathology , Duane Retraction Syndrome/physiopathology , Humans , Oculomotor Muscles/surgery , Strabismus/physiopathology , Trochlear Nerve Diseases/physiopathology , Vision, Binocular/physiologySubject(s)
Accommodation, Ocular , Esotropia/surgery , Decision Making , Eyeglasses , Humans , Keratomileusis, Laser In Situ , Refraction, OcularSubject(s)
Anti-Inflammatory Agents/administration & dosage , Intraocular Pressure , Strabismus/surgery , Administration, Topical , Anti-Inflammatory Agents/adverse effects , Child , Endophthalmitis/prevention & control , Glaucoma/chemically induced , Glaucoma/prevention & control , Glucocorticoids , Humans , Postoperative Care , Tonometry, OcularABSTRACT
PURPOSE: To report our results of medical management of myopia, and add these to the prior literature supporting this practice. METHOD: Retrospective review of the medical records of 35 patient-subjects offered this treatment with adequate followup over a five year period. Treatment consisted of prescription of photochromic gray extra lenses incorporating full myopic correction with a +3.00 bifocal addition, and atropine 1% ophthalmic drops, one in each eye, each night at bedtime. Compliance was monitored based upon mydriasis and cycloplegia. RESULTS: The mean change in refractive error per year was +0.07 diopters for the always compliant group, that is, a decrease in the amount of myopia; -0.18 diopters per year for the sometimes compliant group; and -0.17 diopters for the never compliant group, an increase in the degree of myopia. Statistical comparison of our always compliant group with each of the other two groups using the t-test, yielded a P value of P<.10 in each case, considered to be "medically/clinically significant". Comparison of the mean annual change in refractive error of our always compliant group (+0.07 D/yr) with the mean annual change in re-fractive error in the general population aged 8-15 years (-0.24 D/yr) shows an absolute difference of 0.31 D/yr. This difference is "statistically significant" (t-test) with a P <.02. CONCLUSION: Atropine and bifocals are an appropriate, effective, and safe management for progressive school myopia; and probably also for pathological myopia.
